Szent-Györgyi Prize Archives - NFCR

Szent-Györgyi Prize

Zhen-Yi Wang & Zhu Chen: Quite a Combination

There was a time when if you were diagnosed with acute promyelocytic leukemia, or APL, the prognosis was grim. First discovered in 1957, APL is a form of acute myeloid leukemia, where immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a…...

Read more

Carlo Croce: It’s All About (Trans)Location

“It was a great pleasure because it is so important,” recalls Carlo Croce, M.D., of his 2008 win of the National Foundation for Cancer Research’s Szent-Györgyi Prize for Progress in Cancer Research. “The committee is very selective, and they really want to choose outstanding people who really have made a…...

Read more

Alex Matter: Making Targeted Therapy a Reality

“I was attracted, even as a youngster, by infectious diseases and cancer,” recalls Alex Matter, M.D. That young boy would pursue these passions and, in adulthood, emerge as a leading global authority in the disease field. Now the CEO of the Agency for Science, Technology and Research, or A*STAR, the…...

Read more

Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research

FOR IMMEDIATE RELEASE: February 12, 2019 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 Awardee Has Remained at the Vanguard of Various Cancer Immunotherapy Fields for over Four Decades ROCKVILLE, MD – The National Foundation for Cancer Research…...

Read more

Mary-Claire King: Sharpshooter with Breast Cancer in Her Sights

Cancer is complex. “Simple” is the last word that either layman or scientist would use to describe virtually any aspect of the disease. However, simply put, the health prospects of women worldwide have improved as a result of the laboratory work of Mary-Claire King, Ph.D., winner of the National Foundation…...

Read more

HPV Vaccine Gets Expanded Approval from FDA

The U.S. Food and Drug Administration (FDA) recently approved Gardasil 9, a human papilloma virus (HPV) vaccine, for adults aged 27 to 45. The move could help further spell the end of one of the main causes of a host of communicable cancers. Already approved for patients aged 9 to…...

Read more

Dr. Alfred Saah Talks Funding Innovative Research

Part of Dr. Saah and Merck’s efforts involve collaborating and funding basic scientific research. See why Dr. Saah thinks funding innovative, outside the box research is so essential for the future of medical breakthroughs....

Read more

Bea Mintz: The Pioneer of Transgenics—and So Much More

Changing a cancerous cell into a normal cell would seem to be the very definition of a holy grail: a lofty goal that is all but impossible to achieve. And yet, it has already been done. It was 1975 when the seminal work of Dr. Beatrice (“Bea”) Mintz showed how…...

Read more

Dr. John Schiller Discusses the Power of NFCR Funding

Dr. Schiller and Dr. Lowy’s work is made possible through funding from foundations like NFCR that support innovative outside the box research responsible for major medical discoveries. See why Dr. Schiller thinks funding a wider range of research has the possibility of making a big impact.  ...

Read more

James Allison: The Main Act

“How wonderful that we have met with a paradox. Now we have some hope of making progress.” The words of acclaimed physicist Niels Bohr can be thought to apply to the somewhat counterintuitive notion that by engineering an element of the human body’s wondrous natural defense network to disengage, wellbeing…...

Read more